This review focuses principally on GLP-1 RAs approved for treating both T2DM and obesity: liraglutide, semaglutide, and tirzepatide
For example, studies have found that triple-negative breast cancer (TNBC) competes for Gln uptake in the environment, limiting Gln metabolism in tumor-infiltrating T cells and inhibiting anti-tumor responses
It might seem too good to be true, but increasing your glutathione levels can help make these things happen
Glutathione gets its nickname, "the master antioxidant," from its ability to hunt down and destroy free radicals, which can impact cellular function
Most current claims involve severe gastrointestinal injuries such as gastroparesis, ileus, intestinal obstruction, or persistent vomiting requiring hospitalization or surgical intervention
This guide covers the complete physiology behind GLP-1 weight loss stalls across every major medication, from semaglutide to tirzepatide to retatrutide